[APLS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
20-Dec-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 4.56%
YoY- -60.49%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 12 0 0 0 0 -
PBT -33,334 -21,736 -18,256 -11,573 -12,126 -9,051 -6,620 194.64%
Tax -33,669 267 -17,896 -11,589 -12,138 -9,063 -6,679 194.87%
NP -33,334 -21,736 -18,256 -11,573 -12,126 -9,051 -6,620 194.64%
Tax Rate - - - - - - - -
Total Cost 33,334 21,736 18,267 11,573 12,126 9,051 6,620 194.64%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 -158,169.26 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.61 -0.43 -0.36 -0.30 -0.67 -0.50 -0.37 39.68%
EPS Diluted -0.61 -0.43 -0.36 -0.30 -0.67 -0.50 -0.37 39.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.